PubMed

Is it time to widen the use of somatostatin analogs in neuroendocrine tumors?

Oberg KE.

J Clin Oncol. 2009 Oct 1;27(28):4635-6. Epub 2009 Aug 24. No abstract available. PMID: 19704053 [PubMed - indexed for MEDLINE]Related articles

Treatment with combined streptozotocin and liposomal doxorubicin in metastatic endocrine pancreatic tumors.

Fjallskog ML, Janson ET, Falkmer UG, Vatn MH, Oberg KE, Eriksson BK.

Neuroendocrinology. 2008;88(1):53-8. Epub 2008 Feb 18.PMID: 18285678 [PubMed - indexed for MEDLINE]Related articles

Somatostatin induces rapid contraction of neuroendocrine cells.

Saras J, Grönberg M, Stridsberg M, Oberg KE, Janson ET.

FEBS Lett. 2007 May 15;581(10):1957-62. Epub 2007 Apr 18.PMID: 17462633 [PubMed - indexed for MEDLINE]Related articles

Malignant gastric ghrelinoma with hyperghrelinemia.

Tsolakis AV, Portela-Gomes GM, Stridsberg M, Grimelius L, Sundin A, Eriksson BK, Oberg KE, Janson ET.

J Clin Endocrinol Metab. 2004 Aug;89(8):3739-44.PMID: 15292299 [PubMed - indexed for MEDLINE]Related articlesFree article

High-dose treatment with a long-acting somatostatin analogue in patients with advanced midgut carcinoid tumours.

Welin SV, Janson ET, Sundin A, Stridsberg M, Lavenius E, Granberg D, Skogseid B, Oberg KE, Eriksson BK.

Eur J Endocrinol. 2004 Jul;151(1):107-12.PMID: 15248829 [PubMed - indexed for MEDLINE]Related articlesFree article

Expression of molecular targets for tyrosine kinase receptor antagonists in malignant endocrine pancreatic tumors.

Fjällskog ML, Lejonklou MH, Oberg KE, Eriksson BK, Janson ET.

Clin Cancer Res. 2003 Apr;9(4):1469-73.PMID: 12684421 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment with cisplatin and etoposide in patients with neuroendocrine tumors.

Fjällskog ML, Granberg DP, Welin SL, Eriksson C, Oberg KE, Janson ET, Eriksson BK.

Cancer. 2001 Sep 1;92(5):1101-7.PMID: 11571721 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy and safety of prolonged-release lanreotide in patients with gastrointestinal neuroendocrine tumors and hormone-related symptoms.

Wymenga AN, Eriksson B, Salmela PI, Jacobsen MB, Van Cutsem EJ, Fiasse RH, Välimäki MJ, Renstrup J, de Vries EG, Oberg KE.

J Clin Oncol. 1999 Apr;17(4):1111.PMID: 10561168 [PubMed - indexed for MEDLINE]Related articles

Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors.

Eriksson BK, Larsson EG, Skogseid BM, Löfberg AM, Lörelius LE, Oberg KE.

Cancer. 1998 Dec 1;83(11):2293-301.PMID: 9840528 [PubMed - indexed for MEDLINE]Related articlesFree article

Antibodies to interferon-alpha in treated cancer patients: incidence and significance.

McKenna RM, Oberg KE.

J Interferon Cytokine Res. 1997 Mar;17(3):141-3. Review.PMID: 9085938 [PubMed - indexed for MEDLINE]Related articles

Carcinoid tumours.

Tiensuu Janson EM, Oberg KE.

Baillieres Clin Gastroenterol. 1996 Dec;10(4):589-601. Review.PMID: 9113314 [PubMed - indexed for MEDLINE]Related articles

The use of new somatostatin analogues, lanreotide and octastatin, in neuroendocrine gastro-intestinal tumours.

Eriksson B, Janson ET, Bax ND, Mignon M, Morant R, Opolon P, Rougier P, Oberg KE.

Digestion. 1996;57 Suppl 1:77-80.PMID: 8813476 [PubMed - indexed for MEDLINE]Related articles

Autoimmunity and antibodies to interferons in patients with carcinoid tumors--clinical consequences.

Oberg KE.

J Interferon Res. 1994 Aug;14(4):215-6. No abstract available. PMID: 7822879 [PubMed - indexed for MEDLINE]Related articles

Characterization of anti-interferon-alpha antibodies appearing during recombinant interferon-alpha 2a treatment.

Rönnblom LE, Janson ET, Perers A, Oberg KE, Alm GV.

Clin Exp Immunol. 1992 Sep;89(3):330-5.PMID: 1516252 [PubMed - indexed for MEDLINE]Related articlesFree article

Octreotide and interferon alfa: a new combination for the treatment of malignant carcinoid tumours.

Tiensuu Janson EM, Ahlström H, Andersson T, Oberg KE.

Eur J Cancer. 1992;28A(10):1647-50.PMID: 1382492 [PubMed - indexed for MEDLINE]Related articles

Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors.

Rönnblom LE, Alm GV, Oberg KE.

Ann Intern Med. 1991 Aug 1;115(3):178-83.PMID: 2058872 [PubMed - indexed for MEDLINE]Related articles

Possible induction of systemic lupus erythematosus by interferon-alpha treatment in a patient with a malignant carcinoid tumour.

Rönnblom LE, Alm GV, Oberg KE.

J Intern Med. 1990 Mar;227(3):207-10.PMID: 1690258 [PubMed - indexed for MEDLINE]Related articles

The reversibility of the respiratory inhibition in gills and the ultrastructural changes in chloride cells from the rotenone-poisoned marine teleost, Gadus callarias L.

Oberg KE.

Exp Cell Res. 1967 Mar;45(3):590-602. No abstract available. PMID: 6022569 [PubMed - indexed for MEDLINE]Related articles

THE INHIBITION OF THE RESPIRATION OF BRAIN MITOCHONDRIA OF ROTENONE-POISONED FISH.

OBERG KE.

Exp Cell Res. 1964 Nov;36:407-10. No abstract available. PMID: 14254220 [PubMed - OLDMEDLINE]Related articles

The site of the action of rotenone in the respiratory chain.

OBERG KE.

Exp Cell Res. 1961 Jun;24:163-4. No abstract available. PMID: 13730152 [PubMed - indexed for MEDLINE]Related articles

The effect of rotenone on respiration and its point of attack.

LINDAHL PE, OBERG KE.

Exp Cell Res. 1961 Mar;23:228-37. No abstract available. PMID: 13762256 [PubMed - indexed for MEDLINE]Related articles

Mechanism of the physiological action of rotenone.

LINDAHL PE, OBERG KE.

Nature. 1960 Aug 27;187:784. No abstract available. PMID: 14417054 [PubMed - indexed for MEDLINE]Related articles